Trial intelligence / Profile preview

Tranexamic acid versus conditioned medium for inguinal hyperpigmentation

IRCT20240514061799N1Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, double-blind trial of tranexamic acid and Normal Saline-Benha University in Hyperpigmentation (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Groin darkness degree, Patient satisfaction degree and 1 more. Started Nov 2024; status: completed.

02

Drugs

tranexamic acidNormal Saline-Benha University
03

Conditions

Hyperpigmentation

Beyond the preview

Go deeper on IRCT20240514061799N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240514061799N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call